Virginia Commonwealth University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).
Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.
Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
558 total, page 1 of 12
Integrating a Prescription Produce Program Within a Diabetes Prevention Program
NCT07472712
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
NCT07426913
Comparing the Attentional Demands and Functional Outcomes in People With Transradial Amputation
NCT07075042
A Hospital-based Intervention for Youth Injured Through Violence
NCT07475247
Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA
NCT07415876
Assessing Ambulatory and Non-ambulatory Community Mobility in People With Lower Limb Amputation
NCT07387744
Alveolar Ridge Preservation (ARP) in the Posterior Maxilla After the Extraction of Maxillary Molars
NCT07433322
mHealth Intervention for Pain Self Management
NCT07332377
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
NCT07130695
Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia
NCT07284290
C-SMART vs BE Well for Patients With Brain Tumors
NCT07224503
Redefining BMI: The Body, Mind, and Inflammation Trial
NCT06532747
Enhancing Oral Cancer Awareness
NCT06682494
Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms
NCT07071350
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
NCT06966388
FearLess in NeuroOncology
NCT06989086
Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
NCT06747884
Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
NCT06846463
Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
NCT06981195
Automated Robotic TCD in Traumatic Brain Injury
NCT05848297
Effect of Clear Aligner Attachment Size on Extrusion of Maxillary Lateral Incisors
NCT06814262
Psychobiological Responses Following Exercise and Brain Stimulation
NCT06874595
Safety and Efficacy of LOw DOse COlchicine in Patients With STatin INTolerance: the LODOCO STINT Pilot Study
NCT06874192
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
NCT06892496
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
NCT06728072
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
NCT06636123
Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
NCT06731413
Research Participation With Transgender and Gender-Diverse Youth
NCT05927350
Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs
NCT06382207
A Single-session Intervention Adaptation of the Habit Framework for the Prevention of Eating Disorders
NCT06861608
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
NCT06212791
Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia
NCT06771323
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
NCT06370000
Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program
NCT06688825
Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony (FOCUS-Right)
NCT06601322
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
NCT06714929
Using Dichoptic Therapy to Treat Intermittent Exotropia
NCT06529016
Immune Registry for BK in Kidney Transplant Recipients
NCT06538961
Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Nat hx With Its Numerous Co-morbidities?
NCT06616363
Improving Traumatic Brain Injury Rehab Care With Comm Health Services: a Research Project Within the TBI Model System
NCT06188364
Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation
NCT05947279
A Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults
NCT06239285
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
NCT05424003
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
NCT06237179
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
NCT06062966
LGMD R1 Natural History Study
NCT05618080
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
NCT05958316
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
NCT06185205
Neuroscience-informed Treatment to Remotely Target Reward Mechanisms in Post-acute Anorexia Nervosa
NCT05799872
Long-Term Development of Muscular Dystrophy Outcome Assessments
NCT05989620
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 65 |
| Phase 3 | 13 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the Virginia Commonwealth University pipeline
77 recruiting of 558 indexed (14% open); 380 completed (68%).
Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Virginia Commonwealth University: open-pipeline peers nationwide
Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 558 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Ohio State University · 552 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- BeiGene · 14% recruiting · 65 trials
- Reproductive Medicine Associates of New Jersey · 14% recruiting · 51 trials
- University of Cincinnati · 14% recruiting · 245 trials
Related
What to do with this Virginia Commonwealth University page
558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.
- 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets.Report a data error.